https://doi.org/10.1038/s41388-019-0755-0
D
Demeng Chen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
93
Papers
4.6K
Citations
32
h-index
57
i10-index
Demeng Chen is an academic researcher from South China Agricultural University. The author has contributed to research in topics: RNA modifications and cancer & Epigenetics and DNA Methylation & Cancer-related gene regulation. The author has an h-index of 32, co-authored 80 publications.
ORCID: 0000-0001-7230-2495Papers by this author
worksDynamic m6A mRNA methylation reveals the role of METTL3-m6A-CDCP1 signaling axis in chemical carcinogenesis
2019 · Oncogene · 182 citations
Super enhancer inhibitors suppress MYC driven transcriptional amplification and tumor progression in osteosarcoma
2018 · Bone Research · 138 citations
https://doi.org/10.1038/s41413-018-0009-8
METTL3-mediated m6A mRNA modification promotes esophageal cancer initiation and progression via Notch signaling pathway
2021 · Molecular Therapy — Nucleic Acids · 86 citations
https://doi.org/10.1016/j.omtn.2021.07.007
Conditional ablation of TGF-β signaling inhibits tumor progression and invasion in an induced mouse bladder cancer model
2016 · Scientific Reports · 54 citations
https://doi.org/10.1038/srep29479
CD276 regulates the immune escape of esophageal squamous cell carcinoma through CXCL1–CXCR2 induced NETs
2024 · Journal for ImmunoTherapy of Cancer · 52 citations
https://doi.org/10.1136/jitc-2023-008662
CD276-dependent efferocytosis by tumor-associated macrophages promotes immune evasion in bladder cancer
2024 · Nature Communications · 48 citations
https://doi.org/10.1038/s41467-024-46735-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat